Literature DB >> 2026879

The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.

C C Winter1, B M Carreno, R V Turner, S Koenig, W E Biddison.   

Abstract

Amino acid substitutions were introduced into the 45 pocket of HLA-A2.1 to determine the potential role of this structurally defined feature of class I molecules in viral peptide and alloantigen presentation. The 45 pocket lies below the alpha 1-domain alpha-helix and is composed of five amino acids, three of which differ between HLA-A2.1 and HLA-B37. These two class I molecules have previously been shown to have largely non-overlapping peptide-binding specificities. Site-directed mutagenesis was used to replace the hydrophobic residues at positions 24, 45, and 67 in the 45 pocket of HLA-A2.1 with the hydrophilic amino acids found in these positions in HLA-B37. Thus, three single amino acid mutants were produced: 24A----S, 45 M----T, and 67V----S. These mutants were transfected into HMy2.C1R cells and assessed for their ability to present influenza virus matrix M1 57-68 peptide and HTLV-I Tax-1 2-25 peptide to HLA-A2.1-restricted, peptide-specific CTL and to present alloantigens to HLA-A2-allospecific CTL lines. Each of these substitutions in the 45 pocket produced a molecule that failed to present the M1 peptide to most M1 peptide-specific CTL lines. In contrast, none of these mutations affected presentation of the Tax-1 peptide to Tax-1-specific CTL lines, which indicates that these mutant HLA-A2 molecules can function in viral peptide presentation. Two of the three substitutions in the 45 pocket resulted in lack of recognition by a subset of HLA-A2 allospecific CTL lines. These results demonstrate that the amino acid side chains in the 45 pocket can strongly influence peptide presentation and suggest that the 45 pocket may play a role in determining peptide-binding specificity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026879

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.

Authors:  R A Colbert; S L Rowland-Jones; A J McMichael; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

2.  Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.

Authors:  C E Hioe; D M McKinney; J A Frelinger; M McMillan
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

3.  Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.

Authors:  M Matsui; C E Hioe; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

Review 4.  Peptide binding to MHC class I molecules: implications for antigenic peptide prediction.

Authors:  K C Parker; M Shields; M DiBrino; A Brooks; J E Coligan
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

5.  The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides.

Authors:  G M van Bleek; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

6.  Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.

Authors:  M Kannagi; H Shida; H Igarashi; K Kuruma; H Murai; Y Aono; I Maruyama; M Osame; T Hattori; H Inoko
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Identification of a crucial energetic footprint on the alpha1 helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by tax peptide/HLA-A2-specific T cell receptors.

Authors:  B M Baker; R V Turner; S J Gagnon; D C Wiley; W E Biddison
Journal:  J Exp Med       Date:  2001-03-05       Impact factor: 14.307

8.  Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.

Authors:  Masanori Matsui; Masaaki Kawano; Sho Matsushita; Toshitaka Akatsuka
Journal:  Mol Ther Methods Clin Dev       Date:  2014-07-02       Impact factor: 6.698

9.  Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.

Authors:  S E Buxton; R J Benjamin; C Clayberger; P Parham; A M Krensky
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen A*201 complexes on CD4+ CD25+ T Cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease.

Authors:  Yoshihisa Yamano; Cyril J Cohen; Norihiro Takenouchi; Karen Yao; Utano Tomaru; Hong-Chuan Li; Yoram Reiter; Steven Jacobson
Journal:  J Exp Med       Date:  2004-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.